Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 2 | MIP-1A | 24.0 | 53 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | MIP-1A | 19.0 | 57 | ||||
RA2708 | 2 | MIP-1A | 21.0 | 51 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 64.0 | 73 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 71.0 | 50 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 73.0 | 56 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 66.0 | 70 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 57.0 | 50 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 64.0 | 70 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 79.0 | 44 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | MIP-1A | 98.0 | 35 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 70.0 | 59 | |
N2645 | TNF-a | 100 | ng/mL | 2 | MIP-1A | 62.5 | 60 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 70.0 | 53 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | MIP-1A | 78.0 | 55 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 19.0 | 53 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 23.0 | 58 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 20.0 | 69 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 22.5 | 50 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 21.5 | 58 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 27.5 | 50 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 90.0 | 49 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 117.0 | 63 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 38.5 | 60 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 47.0 | 55 |